7

 · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 2:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 3:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 4:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 5:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 6:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 7:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant